News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
717,807 Results
Type
Article (41314)
Company Profile (291)
Press Release (676197)
Multimedia
Podcasts (65)
Webinars (14)
Section
Business (207139)
Career Advice (2068)
Deals (35787)
Drug Delivery (100)
Drug Development (82043)
Employer Resources (174)
FDA (16323)
Job Trends (15080)
News (349814)
Policy (32931)
Tag
Academia (2585)
Accelerated approval (13)
Adcomms (22)
Allergies (101)
Alliances (50469)
ALS (116)
Alzheimer's disease (1502)
Antibody-drug conjugate (ADC) (157)
Approvals (16342)
Artificial intelligence (334)
Autoimmune disease (29)
Automation (22)
Bankruptcy (364)
Best Places to Work (11708)
BIOSECURE Act (20)
Biosimilars (126)
Biotechnology (213)
Bladder cancer (102)
Brain cancer (37)
Breast cancer (390)
Cancer (3076)
Cardiovascular disease (226)
Career advice (1734)
Career pathing (30)
CAR-T (197)
CDC (32)
Cell therapy (534)
Cervical cancer (24)
Clinical research (67806)
Collaboration (1104)
Company closure (4)
Compensation (766)
Complete response letters (28)
COVID-19 (2667)
CRISPR (63)
C-suite (396)
Cystic fibrosis (116)
Data (3290)
Decentralized trials (2)
Denatured (22)
Depression (69)
Diabetes (357)
Diagnostics (6490)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (149)
Drug pricing (132)
Drug shortages (28)
Duchenne muscular dystrophy (158)
Earnings (88864)
Editorial (45)
Employer branding (21)
Employer resources (150)
Events (116913)
Executive appointments (883)
FDA (18285)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (989)
Gene editing (139)
Generative AI (26)
Gene therapy (419)
GLP-1 (814)
Government (4566)
Grass and pollen (5)
Guidances (320)
Healthcare (18946)
HIV (42)
Huntington's disease (30)
IgA nephropathy (43)
Immunology and inflammation (159)
Immuno-oncology (10)
Indications (43)
Infectious disease (2850)
Inflammatory bowel disease (155)
Inflation Reduction Act (10)
Influenza (71)
Intellectual property (138)
Interviews (318)
IPO (16712)
IRA (47)
Job creations (3753)
Job search strategy (1472)
Kidney cancer (13)
Labor market (57)
Layoffs (511)
Leadership (19)
Legal (8008)
Liver cancer (81)
Longevity (12)
Lung cancer (424)
Lymphoma (227)
Machine learning (15)
Management (58)
Manufacturing (451)
MASH (96)
Medical device (13528)
Medtech (13539)
Mergers & acquisitions (19843)
Metabolic disorders (886)
Multiple sclerosis (101)
NASH (16)
Neurodegenerative disease (138)
Neuropsychiatric disorders (37)
Neuroscience (2241)
NextGen: Class of 2025 (6593)
Non-profit (4519)
Now hiring (51)
Obesity (442)
Opinion (236)
Ovarian cancer (104)
Pain (120)
Pancreatic cancer (133)
Parkinson's disease (194)
Partnered (23)
Patents (337)
Patient recruitment (197)
Peanut (51)
People (58911)
Pharmaceutical (68)
Pharmacy benefit managers (21)
Phase I (21187)
Phase II (29904)
Phase III (22122)
Pipeline (2115)
Policy (218)
Postmarket research (2573)
Preclinical (9054)
Press Release (71)
Prostate cancer (150)
Psychedelics (37)
Radiopharmaceuticals (255)
Rare diseases (489)
Real estate (6083)
Recruiting (68)
Regulatory (23056)
Reports (50)
Research institute (2360)
Resumes & cover letters (358)
Rett syndrome (9)
RNA editing (9)
RSV (53)
Schizophrenia (99)
Series A (162)
Series B (122)
Service/supplier (11)
Sickle cell disease (64)
Special edition (18)
Spinal muscular atrophy (148)
Sponsored (33)
Startups (3702)
State (2)
Stomach cancer (14)
Supply chain (78)
Tariffs (69)
The Weekly (41)
Vaccines (818)
Venture capital (60)
Weight loss (274)
Women's health (48)
Worklife (16)
Date
Today (126)
Last 7 days (670)
Last 30 days (2430)
Last 365 days (31310)
2025 (19392)
2024 (35645)
2023 (40435)
2022 (51647)
2021 (56118)
2020 (54492)
2019 (46923)
2018 (35362)
2017 (32532)
2016 (32058)
2015 (38042)
2014 (31819)
2013 (26857)
2012 (29169)
2011 (29836)
2010 (27941)
Location
Africa (754)
Alabama (64)
Alaska (7)
Arizona (253)
Arkansas (13)
Asia (39276)
Australia (6536)
California (8062)
Canada (2490)
China (713)
Colorado (339)
Connecticut (347)
Delaware (211)
Europe (85148)
Florida (1210)
Georgia (269)
Hawaii (2)
Idaho (60)
Illinois (688)
India (29)
Indiana (381)
Iowa (18)
Japan (243)
Kansas (115)
Kentucky (30)
Louisiana (16)
Maine (64)
Maryland (1088)
Massachusetts (5987)
Michigan (255)
Minnesota (484)
Mississippi (4)
Missouri (97)
Montana (31)
Nebraska (25)
Nevada (89)
New Hampshire (69)
New Jersey (2217)
New Mexico (29)
New York (2222)
North Carolina (1155)
North Dakota (9)
Northern California (3601)
Ohio (250)
Oklahoma (16)
Oregon (34)
Pennsylvania (1741)
Puerto Rico (17)
Rhode Island (39)
South America (1139)
South Carolina (37)
South Dakota (1)
Southern California (3058)
Tennessee (132)
Texas (1214)
United States (29671)
Utah (236)
Virginia (200)
Washington D.C. (72)
Washington State (676)
West Virginia (4)
Wisconsin (70)
717,807 Results for "stellar biotechnologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer
June 23, 2025
·
7 min read
Press Releases
Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025
May 23, 2025
·
11 min read
Press Releases
Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering
July 9, 2025
·
4 min read
Press Releases
Lixte Biotechnology Holdings, Inc. Announces $5.0 Million Private Placement Priced at the Market
July 2, 2025
·
4 min read
Press Releases
Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market
July 3, 2025
·
4 min read
Press Releases
Spiderwort Biotechnologies Inc. Announces Status of Biocompatibility Testing for CelluJuve®
April 30, 2025
·
3 min read
Press Releases
Stellar Health Appoints Chad Turner As New Chief Revenue Officer
November 21, 2024
·
2 min read
Press Releases
UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates
April 23, 2025
·
6 min read
Andall Biosciences Introduces 23WELL: A Breakthrough New Brand with Ovary Care Capsules (1+1) as its Stellar Debut Product
Andall Biosciences Inc., a renowned biotechnology company at the forefront of life science research and applications, has made a significant stride with the introduction of their groundbreaking new product line, 23WELL.
May 8, 2024
·
4 min read
Press Releases
Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-001 Trial Evaluating Zanzalintinib Alone or in Combination with an Immune Checkpoint Inhibitor in Metastatic Colorectal Cancer at ASCO GI 2025
January 27, 2025
·
9 min read
1 of 71,781
Next
